Published in Ophthalmology on June 01, 2007
Triamcinolone Acetonide Injections to Treat Diabetic Macular Edema | NCT00231023
Race- and sex-related differences in retinal thickness and foveal pit morphology. Invest Ophthalmol Vis Sci (2011) 1.76
The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study system for evaluation of optical coherence tomograms: SCORE study report 4. Arch Ophthalmol (2009) 1.06
Current treatments in diabetic macular oedema: systematic review and meta-analysis. BMJ Open (2013) 1.00
Effect of systemic medications on onset and progression of diabetic retinopathy. Nat Rev Endocrinol (2010) 0.94
Use of flucinolone acetonide for patients with diabetic macular oedema: patient selection criteria and early outcomes in real world setting. BMC Ophthalmol (2016) 0.92
Ocular side effects associated with peribulbar injections of triamcinolone acetonide for diabetic macular edema. Retina (2011) 0.88
Emerging pharmacotherapies for diabetic macular edema. Exp Diabetes Res (2012) 0.86
Update on corticosteroids for diabetic macular edema. Clin Ophthalmol (2016) 0.83
Pharmacotherapies for diabetic retinopathy: present and future. Exp Diabetes Res (2007) 0.82
Intravitreal Corticosteroids in the Management of Diabetic Macular Edema. Curr Ophthalmol Rep (2013) 0.81
Potential bias in ophthalmic pharmaceutical clinical trials. Clin Ophthalmol (2008) 0.81
Clinical trials on corticosteroids for diabetic macular edema. World J Diabetes (2013) 0.81
Posterior sub-Tenon injection of triamcinolone acetonide as pretreatment for focal laser photocoagulation in diabetic macular edema patients. Jpn J Ophthalmol (2008) 0.79
Factors associated with visual recovery after sub-Tenon injection of triamcinolone acetonide in diabetic macular edema. Clin Ophthalmol (2012) 0.79
Vitrectomy combined with intravitreal triamcinolone acetonide injection and macular laser photocoagulation for nontractional diabetic macular edema. Korean J Ophthalmol (2013) 0.78
A 5-year follow-up of photocoagulation in diabetic macular edema: the prognostic value of vascular leakage for visual loss. Graefes Arch Clin Exp Ophthalmol (2008) 0.77
Comparison of combination posterior sub-tenon triamcinolone and modified grid laser treatment with intravitreal triamcinolone treatment in patients with diffuse diabetic macular edema. Yonsei Med J (2008) 0.76
Advances in the management of diabetic macular oedema based on evidence from the Diabetic Retinopathy Clinical Research Network. Singapore Med J (2015) 0.76
Spectral-domain optical coherence tomography for macular edema. ScientificWorldJournal (2014) 0.75
Posterior sub-tenon's bevacizumab injection in diabetic macular edema; a pilot study. Saudi J Ophthalmol (2015) 0.75
Diabetic Retinopathy Clinical Practice Guidelines: Customized for Iranian Population. J Ophthalmic Vis Res (2016) 0.75
Diabetic retinopathy (treatment). BMJ Clin Evid (2011) 0.75
Comparison of vitrectomized with nonvitrectomized eyes after subtenon injection of triamcinolone acetonide to treat diabetic macular edema: Retrospective comparative Analysis of an interventional case series. Indian J Ophthalmol (2017) 0.75
Intravitreal bevacizumab versus posterior subtenon triamcinolone in diffuse diabetic macular edema. Int Ophthalmol (2014) 0.75
Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol (1985) 17.20
A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol. Am J Ophthalmol (2003) 9.99
The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology (1984) 5.91
Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology (2006) 5.79
A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology (2005) 3.20
Vascular endothelial growth factor is a critical stimulus for diabetic macular edema. Am J Ophthalmol (2006) 2.50
Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy. Ophthalmology (2006) 2.39
A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema. Ophthalmology (2006) 2.17
Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema. Am J Ophthalmol (2005) 1.99
Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid. Am J Ophthalmol (2000) 1.76
Posterior sub-Tenon's capsule triamcinolone injection combined with focal laser photocoagulation for diabetic macular edema. Ophthalmology (2005) 1.74
Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema. Ophthalmology (2005) 1.22
Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial. Invest Ophthalmol Vis Sci (2005) 1.21
Posterior sub-tenon triamcinolone for refractory diabetic macular edema: a randomized clinical trial. Eur J Ophthalmol (2005) 0.96
Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema. J Diabetes Complications (2006) 0.91
Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science (1998) 13.64
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology (2010) 10.28
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med (1983) 8.82
Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell (2000) 7.48
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med (2015) 7.08
A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med (2000) 7.05
Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest (1981) 6.89
Whole-genome association study of bipolar disorder. Mol Psychiatry (2008) 6.80
Comparative genomes of Chlamydia pneumoniae and C. trachomatis. Nat Genet (1999) 5.81
Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A (1995) 5.66
Genetic diversity and disease control in rice. Nature (2000) 5.34
Restriction endonuclease mapping of the human gamma globin gene loci. Nucleic Acids Res (1979) 4.55
Ribosomal RNA sequence suggests microsporidia are extremely ancient eukaryotes. Nature (1987) 4.40
Application of endonuclease mapping to the analysis and prenatal diagnosis of thalassemias caused by globin-gene deletion. N Engl J Med (1978) 4.34
Two functionally distinct subpopulations of human T cells that collaborate in the generation of cytotoxic cells responsible for cell-mediated lympholysis. J Immunol (1978) 4.33
Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology (2011) 4.15
Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci U S A (1999) 4.05
A monoclonal antibody to human acute lymphoblastic leukaemia antigen. Nature (1980) 3.90
The isolation of antibiotic-resistant salmonella from retail ground meats. N Engl J Med (2001) 3.55
The retained surgical sponge. Ann Surg (1996) 3.46
Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet (2004) 3.45
Evaluation of the Hexaplex assay for detection of respiratory viruses in children. J Clin Microbiol (2001) 2.94
Classification of suicidal behaviors: I. Quantifying intent and medical lethality. Am J Psychiatry (1975) 2.89
Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma. J Clin Oncol (1987) 2.81
Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc Natl Acad Sci U S A (1995) 2.80
Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology (1993) 2.79
Nucleotide sequence and expression of the gene encoding the EcoRII modification enzyme. Nucleic Acids Res (1987) 2.68
Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control study. Ophthalmology (1998) 2.62
The impact of physician bonuses, enhanced fees, and feedback on childhood immunization coverage rates. Am J Public Health (1999) 2.52
Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med (1996) 2.46
The molecular basis of alpha-thalassemias: frequent occurrence of dysfunctional alpha loci among non-Asians with Hb H disease. Cell (1979) 2.41
Hospitalization in the Program of All-Inclusive Care for the Elderly (PACE): rates, concomitants, and predictors. J Am Geriatr Soc (2000) 2.38
Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest (1996) 2.36
Capsule endoscopy structured terminology (CEST): proposal of a standardized and structured terminology for reporting capsule endoscopy procedures. Endoscopy (2005) 2.34
Detection, isolation, and functional characterization of two human T-cell subclasses bearing unique differentiation antigens. J Exp Med (1977) 2.34
Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome. J Gen Virol (1999) 2.33
Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform. Diabetes Care (1994) 2.30
Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders. Proc Natl Acad Sci U S A (1996) 2.30
Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology (1999) 2.25
Purification and properties of the Escherichia coli deoxyribonucleic acid-unwinding protein. Effects on deoxyribonucleic acid synthesis in vitro. J Biol Chem (1974) 2.22
Identification and expression of cephamycinase bla(CMY) genes in Escherichia coli and Salmonella isolates from food animals and ground meat. Antimicrob Agents Chemother (2001) 2.22
Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood (1996) 2.19
Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions. N Engl J Med (1986) 2.16
Markers for primary care: missed opportunities to immunize and screen for lead and tuberculosis by private physicians serving large numbers of inner-city Medicaid-eligible children. Pediatrics (1996) 2.14
3,4-dihydroxyphenylethylamine beta-hydroxylase. Physical properties, copper content, and role of copper in the catalytic acttivity. J Biol Chem (1965) 2.13
Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical Trial. JAMA Ophthalmol (2015) 2.12
Absence of messenger RNA and gene DNA for beta-globin chains in hereditary persistence of fetal hemoglobin. Cell (1976) 2.10
Radiation-induced optic neuropathy: a magnetic resonance imaging study. J Neurosurg (1991) 2.07
3-(3-amino-3-carboxy-n-propyl)uridine. The structure of the nucleoside in Escherichia coli transfer ribonucleic acid that reacts with phenoxyacetoxysuccinimide. Biochemistry (1974) 2.06
Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials. Arch Ophthalmol (2009) 2.06
Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Invest Ophthalmol Vis Sci (2000) 2.05
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial. Ophthalmology (2016) 2.04
Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). Am J Pathol (2000) 2.03
Characterization of Salmonella enterica serotype newport isolated from humans and food animals. J Clin Microbiol (2003) 2.02
Congenital left aortic sinus-left ventricle fistula and review of aortocardiac fistulas. Ann Thorac Surg (1977) 2.01
RANIBIZUMAB PLUS PROMPT OR DEFERRED LASER FOR DIABETIC MACULAR EDEMA IN EYES WITH VITRECTOMY BEFORE ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY. Retina (2015) 1.99
Well-established nucleon resonances revisited by double-polarization measurements. Phys Rev Lett (2012) 1.99
Invited review article: Single-photon sources and detectors. Rev Sci Instrum (2011) 1.98
Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer (2001) 1.94
Five leading U.S. commercial brands of moist snuff in 1994: assessment of carcinogenic N-nitrosamines. J Natl Cancer Inst (1995) 1.92
Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy. Am J Ophthalmol (1997) 1.92
Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy. Am J Ophthalmol (2008) 1.87
Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy. Diabetes Metab Rev (1997) 1.86
Identification and characterization of integron-mediated antibiotic resistance among Shiga toxin-producing Escherichia coli isolates. Appl Environ Microbiol (2001) 1.82
Lightning-induced ocular injury. Arch Ophthalmol (1995) 1.81
Randomized clinical trial of the effects of abdominal drainage after elective hepatectomy using the crushing clamp method. Br J Surg (2006) 1.79
Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine. Aliment Pharmacol Ther (2005) 1.79
High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care (1999) 1.78
Self-regulation of smoking intensity. Smoke yields of the low-nicotine, low-'tar' cigarettes. Carcinogenesis (1995) 1.76
Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes (1999) 1.76
Home Use of an Artificial Beta Cell in Type 1 Diabetes. N Engl J Med (2015) 1.75
Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings. Arch Ophthalmol (2009) 1.72
Getting ready for change. BMJ (1992) 1.72
Tumour hypoxia imaging with [18F]FAZA PET in head and neck cancer patients: a pilot study. Eur J Nucl Med Mol Imaging (2007) 1.70
Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: a possible role for insulin in the regulation of IGFBP-3 protease activity. J Clin Endocrinol Metab (1995) 1.69
A test for the practical evaluation of male fertility by acridine orange (AO) fluorescence. Fertil Steril (1984) 1.68
Kinetic mapping of the antibody combining site by chemical relaxation spectrometry. Biochemistry (1974) 1.68
Two-year results of a randomized controlled trial of a health promotion program in a retiree population: the Bank of America Study. Am J Med (1993) 1.67
Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells. J Biol Chem (2000) 1.67
Stereo nonmydriatic digital-video color retinal imaging compared with Early Treatment Diabetic Retinopathy Study seven standard field 35-mm stereo color photos for determining level of diabetic retinopathy. Ophthalmology (2001) 1.65
Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course. Am J Clin Pathol (2001) 1.65
Randomized trial of IV dexamethasone for acute migraine in the emergency department. Neurology (2007) 1.64
The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia. Leukemia (2009) 1.63
Growth characteristics of virus-transformed cells. Maximum population density, inhibition by normal cells, serum requirement, growth in soft agar, and xenogeneic transplantability. J Exp Med (1970) 1.63
Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients. Leukemia (2002) 1.62
The right to effective education. Behav Anal (1991) 1.62
The inhibition of DNA(cytosine-5)methylases by 5-azacytidine. The effect of azacytosine-containing DNA. Mol Pharmacol (1981) 1.62
Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line. J Natl Cancer Inst (1996) 1.61
Gestational diabetes mellitus. A survey of perinatal complications in the 1980s. Diabetes (1991) 1.61
Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis. J Pathol (2007) 1.60
Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology (2008) 1.60
Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines. Genome Res (2001) 1.59
Transfer of the methyl group from N5-methyltetrahydrofolates to homocysteine in Escherichia coli. Biochem J (1964) 1.59
Multilocus genotyping of Giardia duodenalis reveals striking differences between assemblages A and B. Int J Parasitol (2008) 1.59
Nck/Dock: an adapter between cell surface receptors and the actin cytoskeleton. Oncogene (2001) 1.57
Differences in the locational attainment of immigrant and native-born households with children in New York City. Demography (2001) 1.56
Perforating ocular fishhook injury. Arch Ophthalmol (1992) 1.54
The challenge of patients' unmet palliative care needs in the final stages of chronic illness. Palliat Med (2007) 1.54